People already on blood pressure-lowering medications should watch for blood pressure that drops too low and consult their prescriber about any needed adjustments
Results In Studies 2, 3, and 4, 16% of WEGOVY injection-treated patients and 19% of the placebo-treated patients discontinued therapy
Over five years, NAION developed in 0.087% of the GLP-1 group versus 0.065% of the control group
When taking Semaglutide, you may experience some common side effects, including: Gastrointestinal Issues: Nausea, diarrhea, vomiting, constipation, and abdominal discomfort are frequent, especially when starting treatment or after a dose increase
Manufacturer coupons and savings programs can lower copays for eligible patients, and some pharmacy benefit managers offer lower retail pricing that changes the outofpocket math